When should a patent foramen ovale (PFO) be closed in a patient with a possible transient ischemic attack (TIA)?

When PFO Closure is Indicated After Possible TIA

PFO closure should NOT be routinely performed after TIA alone, as current evidence and guidelines support closure only for confirmed cryptogenic ischemic stroke in carefully selected patients under 60 years of age. 1, 2

Critical Distinction: TIA vs. Stroke

The evidence base for PFO closure is built on patients with confirmed ischemic stroke, not TIA. While TIA patients are included in some observational cohorts for descriptive purposes, PFO closure is not guideline-supported after TIA alone 3. The randomized trials demonstrating benefit specifically excluded or minimally included TIA patients 1, 2.

If Confirmed Stroke (Not Just TIA): Patient Selection Algorithm

Step 1: Age Criterion

• Age <60 years: Proceed with evaluation 1, 2
• Age ≥60 years: Closure rarely indicated; benefits diminish substantially as fewer cryptogenic strokes are caused by paradoxical emboli in older patients, and procedural risks increase 1

Step 2: Confirm Cryptogenic Stroke

The stroke must be nonlacunar and truly cryptogenic after extensive workup excluding:

• Large artery atherosclerosis (>40% stenosis)
• Cardioembolic sources (atrial fibrillation, left atrial thrombus, etc.)
• Small vessel disease (lacunar stroke)
• Other determined etiologies 2

Step 3: Risk Stratification Using RoPE Score

Calculate the Risk of Paradoxical Embolism (RoPE) score (0-10 points):

• Higher scores (9-10) indicate 88% probability PFO is stroke-related
• Lower scores (0-3) indicate only 0-4% probability, similar to general population prevalence 2, 4

Points awarded for:

• Younger age
• No hypertension
• No diabetes
• No prior stroke/TIA
• No smoking
• Cortical infarct on imaging

Step 4: Assess PFO Anatomic Features

High-risk features favor closure:

• Large shunt size (>20 microbubbles or substantial right-to-left shunt)
• Atrial septal aneurysm present 2, 4

Step 5: Apply PASCAL Classification

Combine RoPE score with anatomic features:

• PASCAL "Probable": Young patients, no vascular risk factors, high-risk PFO features → Strong indication for closure (90% relative risk reduction, absolute risk reduction 2.1%) 4
• PASCAL "Possible": Intermediate features → Consider closure
• PASCAL "Unlikely": Older patients with vascular risk factors, no high-risk PFO features → Do not close (no benefit, increased harm) 4

Specific Recommendations by Clinical Scenario

Scenario A: All Options Acceptable

Weak recommendation for PFO closure plus antiplatelet therapy over anticoagulation alone 1

Scenario B: Anticoagulation Contraindicated/Declined

Strong recommendation for PFO closure plus antiplatelet therapy versus antiplatelet therapy alone 1

Scenario C: PFO Closure Contraindicated/Declined

Weak recommendation for anticoagulation over antiplatelet therapy alone 1

Key Contraindications to Closure

Do not proceed with closure if:

• Age ≥60 years (except very unusual circumstances)
• Lacunar stroke pattern
• Alternative stroke etiology identified (even if competing risk is lower, e.g., 40% carotid stenosis)
• Low RoPE score (<3) without high-risk anatomic features
• PASCAL "Unlikely" classification
• Significant comorbidities increasing procedural risk 2, 4

Critical Pitfalls to Avoid

1. Closing PFO after TIA alone: Not evidence-based 3, 5
2. Ignoring alternative etiologies: 44-50% of patients with recurrent events after closure have intracranial arterial stenosis or other causes 6, 7
3. Closing in older patients: Benefits disappear while atrial fibrillation risk increases 1, 4
4. Overlooking hypercoagulable states: 62.5% of recurrent strokes post-closure related to thrombophilia 6

Expected Outcomes

Benefits of closure in selected patients:

• Recurrent stroke rate: 0.47% per year (vs. 1.09% with medical therapy)
• Hazard ratio: 0.41 for stroke recurrence 4

Harms:

• New-onset atrial fibrillation: 9.4% within 45 days (4.46-fold increased risk) 8, 6
• Device-related adverse events: uncommon but include headache, arrhythmias 1, 7

Post-Procedure Management

After closure, monitor for:

• Atrial fibrillation (particularly first 45 days)
• Underlying vascular risk factors requiring optimization
• Antiplatelet therapy continuation (duration varies by protocol) 1, 7

The bottom line: For possible TIA without confirmed stroke on imaging, PFO closure is not indicated. Proceed only if there is documented cryptogenic ischemic stroke in a patient <60 years with favorable risk stratification.